Literature DB >> 12380910

Low prevalence of hepatitis C virus infection in hemodialysis units: effect of isolation?

Ozlem Harmankaya1, Birsen Cetin, Aydoğan Obek, Engin Seber.   

Abstract

Hepatitis C virus (HCV) infection has recently become the major cause of chronic liver disease among patients on chronic hemodialysis. The use of erythropoietin for treatment of anemia has reduced the number of blood transfusions, but the frequency of HCV infection has not declined in hemodialysis units. The exact mode of transmission of HCV within dialysis units is as yet incompletely defined, but there is evidence to support nosocomial transmission by sharing dialysis machines in the hemodialysis unit. We performed a study to estimate the prevalence of HCV infection in our hemodialysis unit and to evaluate the effect of patient isolation and use of devoted dialysis machines for HCV-positive patients on the spread of HCV infection. A total of 168 patients on chronic hemodialysis (92 males and 76 females; mean age 54 +/- 12) were screened for HCV-antibodies (HCV-Ab) before their admission to the dialysis unit. Seropositive patients were isolated and confined to dedicated dialysis machines. Aminotransferases were measured monthly and HCV-Ab screening was performed second or third generation ELISA test every two months. Seropositive patients were tested by the PCR for the detection of HCV-RNA. Between March 1992 and August 2000, eight of 168 patients showed seroconversion. Seropositive patients were also found HCV-RNA positive. Four of these patients have become seropositive after they had undergone hemodialysis in other dialysis centers on holiday, two patients had received blood transfusions within the six months preceding seroconversion. The prevalence of HCV positivity in our hemodialysis unit is 4.7%. The low prevalence of HCV infection of our unit suggests that patient isolation and use of dedicated dialysis machines for seropositive patients decrease the transmission of HCV infection in hemodialysis units.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12380910     DOI: 10.1081/jdi-120013968

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  5 in total

Review 1.  Infection prevention and the medical director: uncharted territory.

Authors:  Toros Kapoian; Klemens B Meyer; Douglas S Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-20       Impact factor: 8.237

2.  Hepatitis C virus infection in haemodialysis: the 'no-isolation' policy should not be generalized.

Authors:  Sanjay Kumar Agarwal; Suresh Chand Dash; Sanjay Gupta; Ravinder Mohan Pandey
Journal:  Nephron Clin Pract       Date:  2009-01-16

3.  A shield against a monster: Hepatitis C in hemodialysis patients.

Authors:  Seyed-Moayed Alavian
Journal:  World J Gastroenterol       Date:  2009-02-14       Impact factor: 5.742

Review 4.  Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis.

Authors:  Nahid Ramezan Ghorbani; Shirin Djalalinia; Mitra Modirian; Zahra Esmaeili Abdar; Morteza Mansourian; Armita Mahdavi Gorabi; Hamid Asayesh; Hossein Ansari; Mehrdad Kazemzadeh Atoofi; Ramin Tajbakhsh; Mehdi Noroozi; Saeid Safiri; Mostafa Qorbani
Journal:  J Res Med Sci       Date:  2017-11-28       Impact factor: 1.852

5.  The role of hemodialysis machines dedication in reducing Hepatitis C transmission in the dialysis setting in Iran: a multicenter prospective interventional study.

Authors:  Alireza Abdollah Shamshirsaz; Mohammad Kamgar; Mir Reza Bekheirnia; Farzam Ayazi; Seyed Reza Hashemi; Navid Bouzari; Mohammad Reza Habibzadeh; Nima Pourzahedgilani; Varshasb Broumand; Amir Hooshang Abdollah Shamshirsaz; Maziyar Moradi; Mehrdad Borghei; Niloofar Nobakht Haghighi; Behrooz Broumand
Journal:  BMC Nephrol       Date:  2004-10-07       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.